psilocybin Archives | Psychedelic Spotlight

Colorado-based Mydecine is launching four new psychedelic candidates for use in treating conditions like anxiety and depression.

Psilocybin is showing relief as treatment for cluster headaches — a painful condition that affects more than 300,000 Americans a year.

This week in psychedelic business news: cannabis dives in, ketamine delivery, and psilocybin for autism anxiety.

Massachusetts General Hospital has launched a new center for psychedelic research. First up: the benefits of psilocybin.

Researchers are looking at how psilocybin and other psychedelics may help with OCD (obsessive-compulsive disorder).

Scientists are closer to unraveling the mystery behind the psilocybin effects and its ability to offer anti-depressive benefits.

Former presidential candidate Andrew Yang wants to decriminalize psilocybin. And if he becomes mayor of New York City, that could happen.

New psychedelic research underway in Australia will look at the success of treating meth addiction with psilocybin.

The first state to legalize therapeutic use of psilocybin, Oregon now has an advisory board to help build its regulations.

Proposed legislation in the state of New York would decriminalize psilocybin, the psychedelic compound in some types of mushrooms.